Ethanol Prevents Microvascular Dysfunction
乙醇预防微血管功能障碍
基本信息
- 批准号:7857912
- 负责人:
- 金额:$ 32.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-15 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseAcidsAddressAdhesionsAdhesivesAlcohol consumptionAlcoholic BeveragesAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsBeerBlood PlateletsCalcitonin Gene-Related PeptideCalcitonin-Gene Related Peptide ReceptorCell Adhesion MoleculesChloride IonChloridesConsumptionCystic Fibrosis Transmembrane Conductance RegulatorCytochrome P450DevelopmentDoseElementsEndothelial CellsEnzymesEpidemiologic StudiesEthanolEventExhibitsFunctional disorderHeartHourIncidenceIndividualIschemiaLeukocyte RollingLeukocytesLinkLipidsMediator of activation proteinMetabolicMicrocirculationMicroscopicMusMutant Strains MiceMyocardial InfarctionNitric OxideP-SelectinPeptide antibodiesPhasePhenotypePlasmaPlayPropertyProtein IsoformsProtein Kinase CReactionReperfusion InjuryReperfusion TherapyResearch PersonnelRoleSecondary toSignal TransductionSurfaceTissuesWineWorkalcohol effectalcohol exposurecalcium-dependent protein kinasedrinkinghuman NOS3 proteinimprovednovelpostcapillary venulepreconditioningpreventprogramsprotein expression
项目摘要
DESCRIPTION (provided by applicant): Ethanol consumption at low to moderate levels protects the heart and vasculature from the deleterious effects of ischemia and reperfusion (I/R). Our recent work indicates that antecedent ethanol ingestion provokes the development of an anti-inflammatory phenotype in postcapillary venules such that these microvessels fail to support leukocyte/endothelial cell adhesive interactions during I/R. Surprisingly, AMP-activated kinase (AMPK) plays a necessary role in initiating this adaptive transformation to a protected phenotype in postcapillary venules. However, it is not clear how this enzyme, best known for its role as a metabolic master switch, is involved in transducing signals elicited by ethanol to effect the acquisition of tolerance to I/R in the microcirculation. Our overall hypothesis is that ethanol-induced, AMPK-dependent eNOS activation serves as an important initiating factor to trigger a cascade of signaling events that ultimately act to promote the expression of cytochrome P450 epoxygenases (CYP), which serve as an important effector of the beneficial microvascular actions of ethanol by catalyzing the formation of reaction products which exhibit powerful anti-adhesive and antioxidant properties. To address this postulate, we propose to determine whether: (1) ethanol-induced AMPK activation initiates the development of an anti-inflammatory phenotype by stimulating the formation of eNOS-derived NO; (2) NO-induced release of calcitonin gene-related peptide (CGRP) plays an essential role in the acquisition of tolerance to ischemia that is evoked by antecedent ethanol consumption; (3) the cystic fibrosis transmembrane regulator (CFTR) serves as an obligatory downstream signaling element that participates in inaugurating the development of the protected phenotype precipitated by ethanol-induced AMPK activation; and (4) ethanol-induced, AMPK-triggered increases in CYP activity during I/R prevents postischemic leukocyte adhesion in postcapillary venules by abrogating P-selectin expression. Intravital microscopic approaches will be used to quantify leukocyte rolling and adhesion in wild-type control mice and in mutant mice lacking AMPK, eNOS, CGRP, or CFTR. The influence of ethanol on l/R-induced adhesion molecule expression, AMPK and eNOS activity, CGRP release, and CYP protein expression and activity will also be investigated. Collectively, these aims address novel mechanisms whereby antecedent ethanol ingestion induces the development of an anti-inflammatory phenotype in postcapillary venules. This work will identify new links between ethanol-induced, AMPK-dependent, eNOS-derived NO formation as essential triggering elements, CGRP release and CFTR function as obligatory downstream mediators, and increased CYP activity as a major effector in the acquisition of tolerance to I/R by antecedent ethanol ingestion.
描述(由申请人提供):低至中等水平的乙醇消耗可保护心脏和脉管系统免受缺血和再灌注(I/R)的有害影响。我们最近的工作表明,先前的乙醇摄入会引起毛细血管后微静脉中抗炎表型的发展,使得这些微血管在 I/R 期间无法支持白细胞/内皮细胞粘附相互作用。令人惊讶的是,AMP 激活激酶 (AMPK) 在毛细血管后微静脉中启动这种向受保护表型的适应性转变中发挥着必要的作用。然而,目前尚不清楚这种酶(以其作为代谢主开关的作用而闻名)如何参与转导乙醇引发的信号以影响微循环中 I/R 耐受性的获得。我们的总体假设是,乙醇诱导的、AMPK 依赖性 eNOS 激活是触发一系列信号事件的重要启动因素,最终促进细胞色素 P450 环氧化酶 (CYP) 的表达,而 CYP 是细胞色素 P450 环氧化酶 (CYP) 的重要效应子。乙醇通过催化反应产物的形成而发挥有益的微血管作用,这些反应产物具有强大的抗粘连和抗氧化特性。为了解决这个假设,我们建议确定是否:(1)乙醇诱导的 AMPK 激活通过刺激 eNOS 衍生的 NO 的形成来启动抗炎表型的发展; (2) NO诱导的降钙素基因相关肽(CGRP)的释放在获得对先前乙醇消耗引起的缺血耐受性中起着重要作用; (3) 囊性纤维化跨膜调节因子 (CFTR) 作为必需的下游信号元件,参与乙醇诱导的 AMPK 激活所促成的受保护表型的发展; (4) I/R期间乙醇诱导的、AMPK触发的CYP活性增加通过消除P-选择素表达来防止毛细血管后微静脉中缺血后白细胞粘附。活体显微镜方法将用于量化野生型对照小鼠和缺乏 AMPK、eNOS、CGRP 或 CFTR 的突变小鼠中的白细胞滚动和粘附。还将研究乙醇对 l/R 诱导的粘附分子表达、AMPK 和 eNOS 活性、CGRP 释放以及 CYP 蛋白表达和活性的影响。总的来说,这些目标解决了先前摄入乙醇诱导毛细血管后微静脉抗炎表型发展的新机制。这项工作将确定乙醇诱导的、AMPK 依赖性的、eNOS 衍生的 NO 形成(作为必需的触发元件)、CGRP 释放和 CFTR 功能(作为必需的下游介质)以及增加的 CYP 活性(作为获得 I 耐受性的主要效应器)之间的新联系。 /R 通过先前的乙醇摄入。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Filling GAPs in the understanding of cardioprotection induced by GPCR activation: RGS proteins modulate ischaemic injury.
填补 GPCR 激活诱导的心脏保护作用的空白:RGS 蛋白调节缺血性损伤。
- DOI:
- 发表时间:2011-07-01
- 期刊:
- 影响因子:10.8
- 作者:Korthuis; Ronald J
- 通讯作者:Ronald J
TRPing up reperfusion: neutrophil TRPM2 channels exacerbate necrosis and contractile dysfunction in post-ischaemic myocardium.
TRP 促进再灌注:中性粒细胞 TRPM2 通道会加剧缺血后心肌的坏死和收缩功能障碍。
- DOI:
- 发表时间:2013-02-01
- 期刊:
- 影响因子:10.8
- 作者:Korthuis, Ronald J;Kalogeris, Theodore
- 通讯作者:Kalogeris, Theodore
Mast Cell Proteases and Inflammation.
肥大细胞蛋白酶和炎症。
- DOI:10.1016/j.ddmod.2011.06.004
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Hongyan Dai;R. Korthuis
- 通讯作者:R. Korthuis
Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO- and p38 MAPK-dependent mechanism.
硫化氢通过 NO 和 p38 MAPK 依赖性机制触发缺血后小肠的后期预处理。
- DOI:
- 发表时间:2009-03
- 期刊:
- 影响因子:0
- 作者:Yusof, Mozow;Kamada, Kazuhiro;Kalogeris, Theodore;Gaskin, F Spencer;Korthuis, Ronald J
- 通讯作者:Korthuis, Ronald J
Isoform-selective 5'-AMP-activated protein kinase-dependent preconditioning mechanisms to prevent postischemic leukocyte-endothelial cell adhesive interactions.
- DOI:10.1152/ajpheart.00944.2010
- 发表时间:2011-04-01
- 期刊:
- 影响因子:0
- 作者:F. Gaskin;Kazuhiro Kamada;M. Zuidema;Allan W. Jones;L. Rubin;R. Korthuis
- 通讯作者:R. Korthuis
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD JOHN KORTHUIS其他文献
RONALD JOHN KORTHUIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD JOHN KORTHUIS', 18)}}的其他基金
Daily Moderate Ethanol Ingestion Attenuates Postischemic Microvascular Dysfunctio
每日适量摄入乙醇可减轻缺血后微血管功能障碍
- 批准号:
8757257 - 财政年份:2015
- 资助金额:
$ 32.05万 - 项目类别:
Daily Moderate Ethanol Ingestion Attenuates Postischemic Microvascular Dysfunctio
每日适量摄入乙醇可减轻缺血后微血管功能障碍
- 批准号:
9017894 - 财政年份:2015
- 资助金额:
$ 32.05万 - 项目类别:
Microvascular Dysfunction: Impact Ischemia-Reperfusion Vascular Cell Interaction
微血管功能障碍:影响缺血再灌注血管细胞相互作用
- 批准号:
7918618 - 财政年份:2010
- 资助金额:
$ 32.05万 - 项目类别:
Venular leukocyte adhesion, impaired arteriolar vasoreactivity, and intestinal IR
小静脉白细胞粘附、小动脉血管反应性受损和肠道 IR
- 批准号:
7569377 - 财政年份:2006
- 资助金额:
$ 32.05万 - 项目类别:
Venular leukocyte adhesion, impaired arteriolar vasoreactivity, and intestinal IR
小静脉白细胞粘附、小动脉血管反应性受损和肠道 IR
- 批准号:
7197453 - 财政年份:2006
- 资助金额:
$ 32.05万 - 项目类别:
Venular leukocyte adhesion, impaired arteriolar vasoreactivity, and intestinal IR
小静脉白细胞粘附、小动脉血管反应性受损和肠道 IR
- 批准号:
7752528 - 财政年份:2006
- 资助金额:
$ 32.05万 - 项目类别:
Venular leukocyte adhesion, impaired arteriolar vasoreactivity, and intestinal IR
小静脉白细胞粘附、小动脉血管反应性受损和肠道 IR
- 批准号:
7340482 - 财政年份:2006
- 资助金额:
$ 32.05万 - 项目类别:
相似国自然基金
AMPK通过调控Smurf1的SUMO化抑制创伤性异位骨化的研究
- 批准号:31900852
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
血管微环境中内皮细胞AMPK抑制心肌纤维化的功能与机制研究
- 批准号:81800273
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于AMPK-FXR-BSEP介导的齐墩果酸所致胆汁淤积性肝损伤作用机制研究
- 批准号:81760678
- 批准年份:2017
- 资助金额:35.0 万元
- 项目类别:地区科学基金项目
基于AMPK信号通路研究菝葜黄酮调控脂类代谢分子机制
- 批准号:81760157
- 批准年份:2017
- 资助金额:32.0 万元
- 项目类别:地区科学基金项目
AMPK通过Wnt/β-catenin信号通路调控绵羊肌内脂肪前体细胞分化的研究
- 批准号:31402053
- 批准年份:2014
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Glyoxalase 1 and its Role in Metabolic Syndrome
乙二醛酶 1 及其在代谢综合征中的作用
- 批准号:
10656054 - 财政年份:2023
- 资助金额:
$ 32.05万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 32.05万 - 项目类别:
Deciphering the Molecular Mechanisms by which PKA inhibits mTORC1
破译 PKA 抑制 mTORC1 的分子机制
- 批准号:
10365712 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别:
Use of SGLT2 inhibition to improve skeletal muscle metabolism in prediabetes
利用 SGLT2 抑制改善糖尿病前期的骨骼肌代谢
- 批准号:
10420977 - 财政年份:2022
- 资助金额:
$ 32.05万 - 项目类别: